Bright Minds Biosciences Inc (DRUG)

Change in Working Capital

-$1.16M

Quarterly · Period ending: · CAD

DRUG logo

DRUG Change in Working Capital

Latest reported-$1.16M CAD
DRUG Quarterly Change in Working Capital · CAD (-$28.32K → -$1.16M)
High-resolution chart · PNG

DRUG change in working capital history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bright Minds Biosciences Inc Change in Working Capital — Quarterly (CAD)
Period endingChange in Working Capital (CAD)
-1,160,262
1,385,071
-996,373
1,191,662
-379,479
-138,628
-118,561
93,387
-153,433
-479,993
579,852
-255,359
-322,000
479,245
-843,603
843,753
-501,355
544,204
-162,469
253,118
6,666
61,874
-15,574
30,685
49,419
-21,098
-28,321
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.